Hugh McTavish
Fondatore presso IGF Oncology LLC
Profilo
Hugh McTavish is the founder of SquareX Pharmaceuticals Corp.
He is the Chairman, President, and Chief Executive Officer of the company, which was founded in 2012.
Dr. McTavish is also the founder of IGF Oncology LLC.
Dr. McTavish received a doctorate degree from the University of Minnesota in 1992.
Posizioni attive di Hugh McTavish
Società | Posizione | Inizio |
---|---|---|
IGF Oncology LLC
IGF Oncology LLC BiotechnologyHealth Technology IGF Oncology LLC develops novel cancer drugs. The company was founded by Hugh McTavish and is headquartered in Pine Springs, MN. | Fondatore | - |
SquareX Pharmaceuticals Corp.
SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | Amministratore Delegato | 26/06/2012 |
Formazione di Hugh McTavish
University of Minnesota | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
IGF Oncology LLC
IGF Oncology LLC BiotechnologyHealth Technology IGF Oncology LLC develops novel cancer drugs. The company was founded by Hugh McTavish and is headquartered in Pine Springs, MN. | Health Technology |
SquareX Pharmaceuticals Corp.
SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | Health Technology |
- Borsa valori
- Insiders
- Hugh McTavish